Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Arlo Technologies, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
185
371
465
370
357
435
490
491
511
529
Cost of revenue
147
279
373
334
302
327
354
324
323
296
Gross profit
38
91.2
92.1
35.8
55.4
108
136
168
188
233
Research and development
24.4
34.7
58.8
69.4
60.1
59.1
64.7
68.6
73.2
73.7
Selling and marketing
18.5
34.3
52.6
57
49.1
48.9
70.1
66.1
73.7
84.8
General and administrative
8.29
15.1
28.2
47.6
51.1
49.5
55.9
56.4
72.1
66.1
Operating expenses
51.2
85.5
167
121
160
168
193
192
222
227
Operating income
-13.1
5.73
-74.8
-85.2
-105
-60.1
-56.9
-24.9
-34.9
6.07
Other non-operating income
-0.51
1.95
-1.18
0.91
3.44
4.78
0.3
4.04
5.48
9.6
Pre-tax income
-13.7
7.68
-74.7
-81.6
-101
-55.4
-55.7
-20.9
-29.4
15.7
Income tax
0.08
1.13
0.77
4.38
0.63
0.68
0.98
1.18
1.09
0.74
Net income
-13.7
6.55
-75.5
-86
-101
-56
-56.6
-22
-30.5
14.9
EBITDA
-11
9.47
-69.5
-74.5
-94.7
-54.2
-52.1
-20.2
-31.7
10
EPS, basic
-0.22
0.11
-1.12
-1.14
-1.30
-0.68
-0.65
-0.24
-0.31
0.14
EPS, diluted
-0.22
0.11
-1.12
-1.14
-1.30
-0.68
-0.65
-0.24
-0.31
0.14
Shares, basic (weighted)
62.3
62.3
67.2
75.1
78.1
82.7
87.2
92.8
98.6
104
Shares, diluted (weighted)
62.3
62.3
67.2
75.1
78.1
82.7
87.2
92.8
98.6
110
Balance sheet
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0.22
0.11
151
237
186
176
84
56.5
82
146
Short-term investments
0
49.7
20
Receivables
158
166
127
77.6
79.6
66
65.4
57.3
39.7
Inventory
83
125
68.6
64.7
38.4
46.6
38.4
40.6
41.2
Other current assets
3.02
23.6
17
8.08
9.92
6.54
10.3
13.2
13.2
Total current assets
244
515
470
357
304
233
251
263
260
Property, plant and equipment
3.88
49.4
21.4
15.8
9.6
7.34
4.76
4.77
13.2
Lease right-of-use assets
0
31.3
24
14.8
12.8
11.5
15.7
9.2
Goodwill
15.6
15.6
15.6
11
11
11
11
11
11
11
Intangible assets
4.35
2.82
1.31
0
0
Other non-current assets
2.19
8.45
4.01
2.4
4.31
4.08
3.62
4.29
4.17
Total assets
270
596
543
414
347
272
286
298
311
Accounts payable
20.7
82.5
112
62.2
84.1
52.1
55.2
63.8
42.8
Accrued liabilities
172
172
127
122
97.4
98.9
88.2
85.7
92.4
Deferred revenue
34.1
26.7
50.4
53.1
29.4
11.3
18
27.2
37.1
Total current liabilities
131
282
294
237
211
162
161
177
172
Lease liabilities
0
29
25
21.5
19.3
17
18.4
6.74
Other non-current liabilities
0
1.14
0.61
1.16
2.44
2.95
3.79
2.37
3.63
Total liabilities
144
326
339
280
235
185
182
197
183
Paid-in capital
315
335
366
401
433
470
499
511
Retained earnings
125
-45.8
-132
-233
-289
-345
-367
-398
-383
Other comprehensive income
0
-0
0
0
-0.11
0.32
0.03
0.02
Shareholders' equity
73.2
125
270
203
134
113
87.7
103
101
128
Total equity
73.2
125
270
203
134
113
87.7
103
101
128
Total liabilities and equity
270
596
543
414
347
272
286
298
311
Shares outstanding
74.2
75.8
79.3
84.5
88.9
95.4
101
105
Cash flow statement
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-13.7
6.55
-75.5
-86
-101
-56
-56.6
-22
-30.5
14.9
Depreciation and amortization
2.13
3.74
5.31
10.7
10.2
5.98
4.77
4.66
3.2
3.93
Stock-based compensation
1.52
2.45
8.83
22.9
35.2
38
48.5
47.9
68.7
62.3
Deferred income tax
-0.67
-0.39
-0.67
-0.2
0.1
-0.33
0.12
0.12
-0.09
-0.16
Change in receivables
-46.3
-75.8
-119
38.2
49.8
-1.74
13.5
0.69
8.23
17.7
Change in inventory
-22.1
-35.6
-48.9
53.6
2.86
29.3
-7.89
7.78
-4.51
-1.43
Change in payables
11.5
-0.35
87.3
28.8
-49.3
22.2
-32.5
3.72
8.29
-21.1
Cash from operations
-33.1
-39
-17.7
9.17
-46.5
-23.2
-46
38.3
51.3
78.7
Capital expenditures
-1.48
-3.58
-21.7
-6.66
-3.89
-2.27
-2.01
-2.85
-2.69
Acquisitions
-8.81
-0.74
0
0
Purchases of investments
0
0
-54.6
-29.8
-50.1
0
-69.3
-150
-205
-113
Cash from investing
-10.3
-4.32
-71.3
76.3
-3.98
17.7
-31.8
-50.7
10.8
27.8
Share buybacks
0
0
-4.42
-45.6
Cash from financing
43.6
43.2
244
-0.04
-0.02
-4.97
-13.9
-15.1
-40.8
-42.1
Net change in cash
0.22
-0.11
155
85.4
-50.5
-10.4
-91.7
-27.5
21.4
64.4
Free cash flow
-34.6
-42.6
-39.4
2.51
-50.4
-25.5
-48
35.5
48.6
Income taxes paid
0
0
0.09
0.96
5.61
0.96
0.42
1.2
1.16
1.22
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $12.84 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
46.0%
Gross profit / revenue.
Operating margin
2.7%
Operating income / revenue.
EBITDA margin
3.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
5.4%
Pre-tax income / revenue.
Net margin
5.2%
Net income / revenue.
Operating cash flow margin
13.3%
Cash from operations / revenue.
Effective tax rate
4.2%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
19.3%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
8.2%
Net income / average total assets.
Return on invested capital (ROIC)
26.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
14.6%
Research and development expense / revenue.
Stock-based pay / revenue
12.2%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
1.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
3.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
2.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
8.2%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
24.2%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
19.6%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
33.3%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y
53.4%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
26.7%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
13.4%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-0.9%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
4.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
4.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-5.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
11.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
8.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
7.1%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.40x
Current assets / current liabilities.
Quick ratio
0.85x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.52x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.28
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$5.30
Revenue / diluted weighted shares.
Operating cash flow per share
$0.71
Cash from operations / diluted weighted shares.
Book value per share
$1.47
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
45.2x
Market cap / net income. Only when net income is positive.
P/S
2.35x
Market cap / revenue.
P/B
8.72x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
16.3x
Market cap / tangible book value, when positive.
P/OCF
17.7x
Market cap / cash from operations, when positive.
EV/Sales
2.18x
Enterprise value / revenue.
EV/EBIT
82.1x
Enterprise value / operating income, when both are positive.
EV/EBITDA
57.0x
Enterprise value / EBITDA, when both are positive.
Earnings yield
2.2%
Net income / market cap (the inverse of P/E).
Shareholder yield
4.3%
(Dividends paid + share buybacks) / market cap.
What was Arlo Technologies, Inc.'s revenue in fiscal 2025?
Arlo Technologies, Inc. reported revenue of $529.3M for fiscal 2025, 3.6% higher than the year before.
Was Arlo Technologies, Inc. profitable in fiscal 2025?
Yes. Net income was $14.9M, a net margin of 2.8%.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.